Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Babak Boroojerdi

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 19, 2002
Pharmacologic influences on TMS effectsBabak Boroojerdi
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|December 28, 2007
Treatment of juvenile stroke using Yamamoto New Scalp Acupuncture (YNSA) - a case reportToshikatsu Yamamoto, Thomas Schockert, Babak Boroojerdi
Journal of Neural Transmission (Vienna, Austria : 1996)|March 20, 2013
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's diseaseNir Giladi, Babak Boroojerdi, Erwin Surmann
Neuropsychologia|August 26, 2004
Shift in sound localization induced by rTMS of the posterior parietal lobeJörg Lewald, Michael Wienemann, Babak Boroojerdi
Neurology|December 10, 2003
Effects of botulinum toxin on motor system excitability in patients with writer's crampBabak Boroojerdi, Leonardo G Cohen, Mark Hallett
Expert Opinion on Pharmacotherapy|July 28, 2011
Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baselineLiesbet Ghys, Erwin Surmann, John Whitesides, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 17, 2010
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's diseaseNir Giladi, Andreas Fichtner, Werner Poewe, et al.
Experimental Brain Research|July 20, 2007
A repetition suppression effect lasting several days within the semantic networkIngo G Meister, Dorothee Buelte, Roland Sparing, et al.
Parkinsonism & Related Disorders|February 14, 2012
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension studyLawrence W Elmer, Erwin Surmann, Babak Boroojerdi, et al.
Archives of Neurology|May 16, 2007
Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson diseaseJoseph Jankovic, Ray L Watts, Wayne Martin, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|November 19, 2002
Pharmacologic influences on TMS effectsBabak Boroojerdi
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|December 28, 2007
Treatment of juvenile stroke using Yamamoto New Scalp Acupuncture (YNSA) - a case reportToshikatsu Yamamoto, Thomas Schockert, Babak Boroojerdi
Journal of Neural Transmission (Vienna, Austria : 1996)|March 20, 2013
The safety and tolerability of rotigotine transdermal system over a 6-year period in patients with early-stage Parkinson's diseaseNir Giladi, Babak Boroojerdi, Erwin Surmann
Neuropsychologia|August 26, 2004
Shift in sound localization induced by rTMS of the posterior parietal lobeJörg Lewald, Michael Wienemann, Babak Boroojerdi
Neurology|December 10, 2003
Effects of botulinum toxin on motor system excitability in patients with writer's crampBabak Boroojerdi, Leonardo G Cohen, Mark Hallett
Expert Opinion on Pharmacotherapy|July 28, 2011
Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baselineLiesbet Ghys, Erwin Surmann, John Whitesides, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 17, 2010
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's diseaseNir Giladi, Andreas Fichtner, Werner Poewe, et al.
Experimental Brain Research|July 20, 2007
A repetition suppression effect lasting several days within the semantic networkIngo G Meister, Dorothee Buelte, Roland Sparing, et al.
Parkinsonism & Related Disorders|February 14, 2012
Long-term safety and tolerability of rotigotine transdermal system in patients with early-stage idiopathic Parkinson's disease: a prospective, open-label extension studyLawrence W Elmer, Erwin Surmann, Babak Boroojerdi, et al.
Archives of Neurology|May 16, 2007
Transdermal rotigotine: double-blind, placebo-controlled trial in Parkinson diseaseJoseph Jankovic, Ray L Watts, Wayne Martin, et al.
Pageof 7